K-RITH and Africa Centre have joined to form a new interdisciplinary institute, called the Africa Health Research Institute. Click here to read more.

x

K-Rith

Learn more
about K-RITH
READ MORE

K-RITH conducts cutting-edge scientific research on TB and HIV and aims to translate the findings into new tools to control these diseases.

Research

Using mobile technologies to test and treat those hardest hit by HIV

Mobile phone-connected HIV tests, which link to online prevention and medical care, are being developed by a team involving Africa Health Research Institute (AHRI) researchers for use in South African communities hardest hit by HIV. The new £600 000 (R10,5-million) m-Africa collaboration, for which funding was announced recently by the UK Medical Research Council (MRC), aims

read more

Research

HIV patients show signs of multidrug resistance in Sub-Saharan Africa

Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by Africa Health Research Institute (AHRI) and UCL researchers, and funded by Wellcome Trust. The research, co-authored by researchers at the London School of Hygiene and Tropical Medicine and published in

read more

Our Scientists

Adrie Steyn

STEYN LAB

The main goal of the Steyn Lab’s research is to understand the mechanisms whereby Mycobacterium tuberculosis persist for decades without causing disease, to then suddenly explode.

READ MORE

Al Leslie

LESLIE LAB

The Leslie Lab investigates the innate immune response to HIV and TB and how novel aspects of this response may potentially be exploited to improve patient outcomes.

READ MORE

Alex Sigal

SIGAL LAB

The aim of the Sigal Lab is to understand HIV and TB transmission between cells and how it affects the persistence of infection, sensitivity to drugs, rate of the infection cycle and, for HIV, the formation of a quasispecies.

READ MORE

Alexander Pym

PYM LAB

The Pym Lab focusses on understanding how the TB bacterium is able to tolerate or resist antibiotics.

READ MORE

Frederick Balagaddé

BALAGADDE LAB

The Balagaddé lab hosts the first microfluidic chip-making foundry in Africa. They are developing medical microchip systems to help control the HIV and TB co-epidemic in South Africa and beyond.

READ MORE

Thumbi Ndung'u

NDUNG'U LAB

The goal of the Ndung’u laboratory is to understand immune mechanisms against HIV and tuberculosis, and pathogen evasion of immune responses as a pathway to vaccine development.

READ MORE
NEWS | Research

Using mobile technologies to test and treat those hardest hit by HIV

Mobile phone-connected HIV tests, which link to online prevention and medical care, are being developed by a team involving Africa Health Research Institute (AHRI) researchers for use in South African communities hardest hit by HIV. The new £600 000 (R10,5-million) m-Africa collaboration, for which funding was announced recently by the UK Medical Research Council (MRC), aims

READ MORE
NEWS | Research

AHRI Bioengineering lab files two new patents

The Africa Health Research Institute’s Frederick Balagaddé and his team have recently filed two new patents relating to microfluidic device automation and screening for efflux pump displacers. Balagaddé heads up the AHRI Bioengineering Laboratory, which is host to the first microfluidic chip-making foundry in Africa. Our scientists are working to develop high throughput research platforms

READ MORE
NEWS | K-RITH

‘WhatsApp for machines’: AHRI files innovative new patent

We all know how WhatsApp works.  Now we have ‘WhatsApp for machines’, where machines are brought into the conversation with humans. And the good news is, it’s homegrown. In a real-world example of leveraging the power of the ‘Internet of Things’, the Africa Health Research Institute (AHRI), working together with facility management company Property Services

READ MORE

Search below for content